87 related articles for article (PubMed ID: 21328371)
21. [Study on the replication of Hepatitis B Virus in primary hepatocytes from heterogenous species].
Yao YQ; Zhang DF; Huang AL; Tang N; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):25-8. PubMed ID: 14761278
[TBL] [Abstract][Full Text] [Related]
22. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
Song JW; Zhang G; Lin JG; Tang WX; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
[TBL] [Abstract][Full Text] [Related]
24. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
25. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
26. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
Zoulim F
Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
[TBL] [Abstract][Full Text] [Related]
28. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
Wakui Y; Inoue J; Ueno Y; Fukushima K; Kondo Y; Kakazu E; Obara N; Kimura O; Shimosegawa T
Biochem Biophys Res Commun; 2010 May; 396(2):508-14. PubMed ID: 20430009
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
31. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
33. [The present state of research in direct antiviral mechanism of interferon on hepatitis B virus].
Liu F; Tang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1358-62, 1371. PubMed ID: 20095503
[TBL] [Abstract][Full Text] [Related]
34. Fungal metabolite myriocin promotes human herpes simplex virus-2 infection.
Wang J; Guo X; Yang Z; Tan RX; Chen X; Li E
Life Sci; 2015 Jan; 120():31-8. PubMed ID: 25447452
[TBL] [Abstract][Full Text] [Related]
35. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.
Suri D; Schilling R; Lopes AR; Mullerova I; Colucci G; Williams R; Naoumov NV
J Hepatol; 2001 Dec; 35(6):790-7. PubMed ID: 11738107
[TBL] [Abstract][Full Text] [Related]
36. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.
Li WY; Ren JH; Tao NN; Ran LK; Chen X; Zhou HZ; Liu B; Li XS; Huang AL; Chen J
Arch Virol; 2016 Mar; 161(3):621-30. PubMed ID: 26660162
[TBL] [Abstract][Full Text] [Related]
37. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
Lee YS; Choi KM; Lee S; Sin DM; Lim Y; Lee YM; Hong JT; Yun YP; Yoo HS
Cancer Biol Ther; 2012 Jan; 13(2):92-100. PubMed ID: 22336910
[TBL] [Abstract][Full Text] [Related]
38. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.
Wieland SF; Vega RG; Müller R; Evans CF; Hilbush B; Guidotti LG; Sutcliffe JG; Schultz PG; Chisari FV
J Virol; 2003 Jan; 77(2):1227-36. PubMed ID: 12502840
[TBL] [Abstract][Full Text] [Related]
39. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis B virus (HBV) replication in animal models and their applications].
Hiasa Y; Onji M
Nihon Rinsho; 2011 May; 69 Suppl 4():363-8. PubMed ID: 22096945
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
